Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.

Source:http://linkedlifedata.com/resource/pubmed/id/15112270

Cancer 2004 May 1 100 9 1892-901

Download in:

View as

General Info

PMID
15112270